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Abstract
The distinction between the Ehlers-Danlos syndrome hypermobile type (EDSH)
and the benign joint hypermobility syndrome (BJHS) is unclear. The aim of the
present study was to compare skin ultrastructural abnormalities of EDSH and
BJHS among different families. Skin of 23 EDSH, 27 BJHS, and 41 asymptomatic
subjects from 17 families was examined using transmission electron microscopy.
Similar ultrastructural abnormalities were found irrespective of the Beighton
score. Flower-like collagen fibrils represented the key change and elastic fibers
were altered as well. Beighton score is a clinical parameter rating joint mobility
that appeared unrelated to quantitative and qualitative collagen ultrastructural
alterations in the skin. Some EDSH family members fit with BJHS diagnosis.
BJHS possibly represents a mild variant of EDSH.
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The distinction between the Ehlers-Danlos syndrome hypermobile type (EDSH) and the benign joint hypermobility syndrome
(BJHS) is unclear. The aim of the present study was to compare skin ultrastructural abnormalities of EDSH and BJHS among
diﬀerent families. Skin of 23 EDSH, 27 BJHS, and 41 asymptomatic subjects from 17 families was examined using transmission
electron microscopy. Similar ultrastructural abnormalities were found irrespective of the Beighton score. Flower-like collagen
fibrils represented the key change and elastic fibers were altered as well. Beighton score is a clinical parameter rating joint mobility
that appeared unrelated to quantitative and qualitative collagen ultrastructural alterations in the skin. Some EDSH family members
fit with BJHS diagnosis. BJHS possibly represents a mild variant of EDSH.
1. Introduction
Ehlers-Danlos syndrome (EDS) is a cluster of inherited
connective tissue disorders, mainly characterized by skin
hyperextensibility, joint hyperlaxity, and tissue fragility.
Both the classical and hypermobile (EDSH) EDS types are
recognized as the most frequent presentations [1]. The
prevalence of EDSH is estimated to range from 1/5,000 to
1/20,000. The major diagnostic criteria for EDSH are joint
hypermobility associated with skin hyperextensibility and/or
velvety aspect [2]. Recurrent joint dislocations, chronic
joint/limb pain, and positive family history are considered
as minor diagnostic criteria. Of note, joint laxity is common
in healthy children under 5 years of age and appears to
be related to gender and race [3–5]. Women usually show
more extensive joint laxity than men. African, Asian, and
Middle Eastern people present a similar physiological feature
[6, 7].
Abnormal joint mobility is conveniently assessed using
the Beighton scale. A score reaching 5/9 or above defines
EDSH. Type III collagen [8] and tenascin-X [9] were
reported to be mutated, but molecular abnormalities remain
often undisclosed. By contrast, dermal ultrastructural fea-
tures are commonly indicative [10–12].
Joint laxity is further present in the benign joint hyper-
mobile syndrome (BJHS) [5] identified using the Brighton
criteria [13]. The Beighton score must reach at least 4, and
arthralgia be present in 4 or more joints for more than 3
months. Minor criteria combine a lower Beighton score and
subluxation in more than one joint or in a single joint on
more than one occasion as well as skin hyperextensibility
and abnormal scarring. According to these definitions, the
diagnostic criteria of EDSH and BJHS overlap. Accordingly,
EDSH and BJHS are considered to be the same disorder by
some authors [11, 14–17].
The aim of the present work was to revisit ultrastructural
features in the skin of EDSH patients and their family
members showing a lower Beighton score and/or with BJHS
criteria.
2. Methods
A total of 91 consecutive patients, aged 9–62 years, from
17 families were explored using transmission electron
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Table 1: Frequency of finding flower-like collagen fibrils (FCF) in
patients with Ehlers-Danlos syndrome hypermobile (EDSH) and in
patients with the benign joint hypermobility syndrome (BJHS).
Disease status Number of patients Number of cases with FCF
EDSH 23 23
BJHS 27 27
Unaﬀected 41 15
microscopy. They were referred to rheumatology depart-
ments for familial joint hyperextensibility. Clinical assess-
ments and skin biopsies were performed with the consent
of the patients or the parents of minors. A total of 23
patients (20 women and 3 men) from the 17 families had a
provisional diagnosis of EDSH according to the Villefranche
nosology [1], and 68 other members of these 17 families
presented with a Beighton score 4/9 or lower. A total of
27/68 subjects (18 men and 9 women) suﬀered from BJHS
as defined by the Brighton criteria.
Skin samples were prepared for transmission electron
microscopy. They were immersed in 4% glutaraldehyde in
a phosphate buﬀer at pH 7.4, postfixed in 1% osmium
tetroxide, and embedded in epon. The ultrathin sections
were double-stained with uranyl acetate and lead citrate.
Observations were made under a Zeiss EM910 electron
microscope operated at 60 kV. The diagnostic criteria were
previously discussed [10, 12].
3. Results
The study started April 2008 until September 2011. The
majority 65/91 of the skin samples (Table 1) showed flower-
like collagen fibrils (FCF) in the papillary and/or reticu-
lar dermis (Figure 1). FCF were observed in all patients
with EDSH and BJHS diagnosis, and in 15 apparently
asymptomatic subjects as well. No gender influence was
disclosed in the ultrastructural changes. The FCF numbers
varied and appeared unrelated to the Beighton score.
Other abnormalities of the connective tissue extracellular
matrix (ECM) consisted of variable collagen fibril diameters,
twisted collagen fibrils, irregular interfibrillar spacing, and
granulofilamentous deposits inside the collagen bundles as
well as whirled or disorganized bundles. The elastic fiber
changes consisted of frayed contours, increased osmiophilic
structures even in young subjects, and inclusions of cal-
cified (Figure 2) or uncalcified microcavities. Large stellate
globules of superposed hyaluronic acid (Figure 3) and focal
granulofilamentous deposits were disclosed in the interstitial
ECM.
Intrafamilial dermal changes generally looked similar. In
a 3/17 families, dermal changes were found in both parents. A
total of 26 asymptomatic subjects of these families exhibited
normal ultrastructural dermal features.
4. Discussion
Subjects with a Beighton score lower than 5/9 were not
clinically considered as EDS. However, they showed dermal
Figure 1: Flower-like collagen fibrils () and irregular interfibrillar
spaces.
Figure 2: Calcified microcyst in an elastic fiber.
Figure 3: Globules of presumably hyaluronic acid and granulofila-
mentous meshwork inside the collagen bundles.
abnormalities including FCF as described earlier [10–12,
18]. In addition, ultrastructural ECM abnormalities were
presently found in asymptomatic or low Beighton score
subjects of EDS family pedigrees. These subjects possibly
presented a subclinical EDS, or their joint hyperlaxity
had possibly vanished with ageing and/or arthrosis. The
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presence of the dermal abnormalities was consistent with the
genetic transmission of EDS morphological features from
asymptomatic parents to their children. According to the
Brighton criteria, 27 of the EDS family members fitted with
BJHS diagnosis, and their dermal ECM showed typical EDS
ultrastructural abnormalities. Accordingly, we support the
concept that BJHS represents a mild variant of EDSH [14–
17].
In spite of the relatively unspecific ultrastructural criteria
of EDS, the global architecture and the ultrastructure of
the dermal ECM are of diagnostic relevance, and they
occasionally suggest a specific EDS type. For instance,
abundant granulofilamentous deposits are found in subjects
with mutations in the gene coding for tenascin-X. For
these reasons, ultrastructural examination of the dermis is
potentially helpful for confirming the diagnosis of EDS,
and for disclosing some family members carrying the ECM
alterations. The defects in collagen fibril formation are likely
multiple suggesting variable penetrance.
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